These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22564737)
1. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis. Patel D; Chaudhary J Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737 [TBL] [Abstract][Full Text] [Related]
2. Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells. Carey JP; Knowell AE; Chinaranagari S; Chaudhary J Anticancer Res; 2013 Oct; 33(10):4271-8. PubMed ID: 24122992 [TBL] [Abstract][Full Text] [Related]
3. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Asirvatham AJ; Carey JP; Chaudhary J Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499 [TBL] [Abstract][Full Text] [Related]
4. Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells. Patel D; Chinaranagari S; Chaudhary J Am J Cancer Res; 2015; 5(11):3407-21. PubMed ID: 26807321 [TBL] [Abstract][Full Text] [Related]
5. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells. Strong N; Millena AC; Walker L; Chaudhary J; Khan SA Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149 [TBL] [Abstract][Full Text] [Related]
6. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415 [TBL] [Abstract][Full Text] [Related]
7. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity. Sharma P; Chinaranagari S; Chaudhary J Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840 [TBL] [Abstract][Full Text] [Related]
8. Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Sharma P; Patel D; Chaudhary J Cancer Med; 2012 Oct; 1(2):187-97. PubMed ID: 23342268 [TBL] [Abstract][Full Text] [Related]
9. Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells. Liu Q; Wu Y; Yoshizawa T; Yan X; Morohashi S; Seino H; Kato Y; Kijima H Int J Mol Med; 2016 Dec; 38(6):1727-1733. PubMed ID: 27840924 [TBL] [Abstract][Full Text] [Related]
10. E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer. López-Menéndez C; Vázquez-Naharro A; Santos V; Dubus P; Santamaría PG; Martínez-Ramírez Á; Portillo F; Moreno-Bueno G; Faraldo MM; Cano A Cancer Res; 2021 Sep; 81(17):4529-4544. PubMed ID: 34145034 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expression in esophageal squamous cell carcinoma. Li ZX; Sun MC; Fang K; Zhao ZY; Leng ZY; Zhang ZH; Xu AP; Chu Y; Zhang L; Lian J; Chen T; Xu MD Cancer Biol Ther; 2023 Dec; 24(1):2246206. PubMed ID: 37607071 [TBL] [Abstract][Full Text] [Related]
12. The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells. Kardava L; Yang Q; St Leger A; Foon KA; Lentzsch S; Vallejo AN; Milcarek C; Borghesi L Int Immunol; 2011 Jun; 23(6):375-84. PubMed ID: 21551245 [TBL] [Abstract][Full Text] [Related]
13. E2A/HEB and Id3 proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression. Ko M; Ahn J; Lee C; Chung H; Jeon SH; Chung HY; Seong RH J Biol Chem; 2004 May; 279(21):21916-23. PubMed ID: 15016815 [TBL] [Abstract][Full Text] [Related]
14. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Voronova AF; Lee F Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells. Schnepp PM; Shelley G; Dai J; Wakim N; Jiang H; Mizokami A; Keller ET Mol Cancer Res; 2020 Sep; 18(9):1290-1301. PubMed ID: 32513898 [TBL] [Abstract][Full Text] [Related]
17. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells. Asirvatham AJ; Schmidt MA; Chaudhary J Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417 [TBL] [Abstract][Full Text] [Related]
18. The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. Kim W; Kook S; Kim DJ; Teodorof C; Song WK J Biol Chem; 2004 Feb; 279(9):8333-42. PubMed ID: 14660614 [TBL] [Abstract][Full Text] [Related]
19. The transcription factor E2A drives neural differentiation in pluripotent cells. Rao C; Malaguti M; Mason JO; Lowell S Development; 2020 Jun; 147(12):. PubMed ID: 32487737 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the bHLH transcription factor E2A in epithelial cells by interaction with the Na/K-ATPase beta1 subunit. Plotkin M; Pelger L Arch Biochem Biophys; 2008 Dec; 480(1):68-74. PubMed ID: 18727914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]